Quick Takeaways
- Leslie Holsinger has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $139,195.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Leslie Holsinger
- Location
- South San Francisco, CA
- Summary
- The estimated net worth of Leslie Holsinger is at least $139,195 dollars as of 08 Jun 2022. Leslie Holsinger is the EVP, Preclinical Development of Cortexyme, Inc. and owns shares of Quince Therapeutics, Inc. (QNCX) stock worth about $139.2K.
- Signature
- /s/ Caryn Gordon McDowell, as Attorney-in-Fact for Leslie Holsinger
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Leslie Holsinger and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Cortexyme, Inc. ($139,195).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Leslie Holsinger
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| QNCX | Cortexyme, Inc. | EVP, Preclinical Development | $139,195 | 06 Jun 2022 |
Insider Transactions Reported by Leslie Holsinger:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.